B. Braun Melsungen

What B. Braun Melsungen does

B. Braun Melsungen, operating through its parent entity B. Braun SE, is a privately held German medical technology and pharmaceutical company founded in 1839 and headquartered in Melsungen, Germany. The company develops, manufactures, and distributes a broad portfolio of medical devices, surgical instruments, pharmaceuticals, and integrated healthcare solutions organized across 19 therapy areas, including infusion therapy, wound management, interventional vascular therapy, neurosurgery, oncology, orthopaedic and spine surgery, robotic surgery, infection prevention, and extracorporeal blood treatment. Its product portfolio is anchored by the Aesculap surgical division (surgical instruments, sterile container systems, power systems) and includes the Original Perfusor infusion line and Smart Infusion Management digital solutions, as well as the Aesculap Aeos Digital Microscope for neurosurgical visualization. Core technology spans proprietary medical devices, closed-system drug transfer devices, hydrocolloid wound dressings, dialysis systems, and connected digital platforms for infusion pump and surgical supply chain management.

The company generates revenue primarily through hardware sales of medical devices and solutions to hospitals, healthcare providers, home care services, dialysis centers, clinical laboratories, and oncology departments across more than 60 countries in Africa, Asia Pacific, Europe, North America, and South America. Distribution is executed through direct enterprise sales forces, regional subsidiaries, an online product catalog, and a B2B partner network. The Aesculap Academy provides professional education and training services, while customized procedure kits, technical service offerings, and discharge management services provide recurring engagement. In fiscal year 2025, B. Braun reported group sales of €9.4 billion, representing 5.1% growth at constant currencies. The company is family-owned with no public listing, and is led by CEO Anna Maria Braun, LL.M., supported by a Management Board and Supervisory Board chaired by Prof. Dr. Thomas Rödder.

Name

B. Braun Melsungen

Legal name

B. Braun SE

Website

https://bbraun.com

Company type

Private

Founded year

1839

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

B. Braun Melsungen (B. Braun SE) is a privately held German medical technology company founded in 1839 that develops and supplies medical devices, pharmaceuticals, and integrated healthcare solutions across 19 therapy areas, serving hospitals, home care providers, and dialysis centers globally through direct sales in 60+ countries.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Pharmaceutical Preparation Manufacturing (325412)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845), Pharmaceutical Preparations (2834)

akta.pro primary industry

Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)

akta.pro secondary industries

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO), Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI), Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)

Keywords

• Medical devices
• Infusion therapy
• Surgical instruments
• Healthcare solutions
• Dialysis equipment

Headquarters

HQ city

Melsungen

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Devices and Solutions: B. Braun generates revenue through the sale of medical devices, surgical instruments, infusion therapy products, and healthcare solutions. Group sales reached €9.4 billion in fiscal year 2025 with 5.1% growth at constant currencies.
2. Aesculap Academy Training Services: The company provides professional education and training services through the Aesculap Academy, supporting healthcare professionals in skill development and continuing education.
3. Technical Service and Support: Technical service offerings including maintenance, support, and product security services for medical equipment.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels9 records

Core offering

B. Braun develops, manufactures, and supplies medical devices, pharmaceuticals, and integrated healthcare solutions across 19 therapy areas including infusion therapy, surgical instruments, wound management, interventional vascular therapy, minimally invasive surgery, neurosurgery, and extracorporeal blood treatment. The company also provides professional training through its Aesculap Academy and customized procedure kits tailored to healthcare facility workflows.

Product overview

B. Braun is a comprehensive medical technology company offering a broad portfolio of medical devices, pharmaceuticals, and services organized across therapy categories and solutions. The company operates through its Aesculap surgical division and multiple therapy areas including infusion therapy, wound management, pain therapy, and surgical specialties. Products span surgical instruments and power systems, closed-system drug transfer devices, infusion pumps, dialysis equipment, and advanced wound care dressings. The portfolio includes connected smart infusion management software, surgical asset management solutions, and the Aesculap Academy for professional training. B. Braun serves hospital, outpatient, and home care settings through a globally distributed network.

Differentiator

Problem solved

Functional benefit

Brands

• Aesculap: Surgical instruments and sterile container systems brand for minimally invasive surgery and other surgical procedures.
• Original Perfusor

Products and services

• Infusion Therapy
• Aesculap Surgical Instruments and Sterile Container Systems
• Interventional Vascular Therapy
• Minimally Invasive Surgery
• Robotic Surgery
• Spine Surgery
• Orthopaedic Surgery
• Wound Management
• Extracorporeal Blood Treatment Therapies
• Infection Prevention and Control
• Pain Therapy
• Oncology
• Surgical Power Systems
• Sutures & Surgical Specialties
• Neurosurgery
• Smart Infusion Management
• Surgical Asset & Supply Management
• Extracorporeal Blood Treatment Therapies - Dialysis Care Centers
• Continence Care and Urology
• Ostomy Care
• Nutrition Therapy
• Dental Care
• Aesculap Academy
• Customized Kits
• Technical Service
• Home Care

Quantifiable outcome

• Group sales increased 5.1% at constant currencies in fiscal year 2025 to €9.4 billion

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• AesculapcoreStrategic or Co-development PartnerAesculap is a core subsidiary brand of B. Braun focusing on surgical instruments and sterile container systems. Aesculap Academy provides professional education and training for healthcare professionals. The partnership represents an integrated internal capability for product development and medical education.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Stryker: US-listed medical device leader in surgical power tools, orthopedic implants, and surgical equipment. Direct competitor in orthopedic power tools where both are listed as major market players.
• Fresenius SE & Co. KGaA: German-based medical technology and healthcare group operating infusion solutions, dialysis (Fresenius Medical Care), and hospital products. Most direct European peer with overlapping infusion therapy, dialysis, and hospital-focused portfolios.
• Nipro Corporation: Japan-based global medical device company producing dialysis, infusion, injection, and surgical products. Direct competitor in vial adaptors and broader hospital device categories where B. Braun operates.
• Becton Dickinson (BD): US-based global medical technology company with overlapping portfolios in infusion therapy, injection/infusion devices, surgical instruments, and medication management. Listed alongside B. Braun in the vial adaptor market.
• Zimmer Biomet: US-listed orthopedic and surgical device company. Direct competitor in orthopedic power tools, joint reconstruction, and surgical instruments where B. Braun operates.
• Smith+Nephew: UK-listed medical device company in advanced wound management, orthopedics, and sports medicine. Direct peer in wound care (hydrocolloid dressings) and orthopedic surgical instruments.
• Baxter International: US-listed global medical products company with overlapping infusion pumps, IV solutions, dialysis, and surgical products portfolios. Closely comparable in hospital-channel infusion and renal therapy offerings.
• ICU Medical: US-listed medical device company specializing in IV infusion therapy, oncology CSTD, and critical care medical connectors. Direct competitor in infusion and closed-system drug transfer devices, named alongside B. Braun in the vial adaptor market.

Broad incumbents

• Johnson & Johnson (Ethicon): Global healthcare conglomerate; Ethicon division directly competes with B. Braun in sutures, stapling, and surgical specialties. Listed alongside B. Braun as a major player in surgical stapling and orthopedic power tools.
• Medtronic: Global medical device leader across cardiovascular, surgical, and diabetes. Overlaps with B. Braun in interventional vascular therapy and surgical stapling, where both are profiled as major market players.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/bbraun
• Facebookfacebook.com/bbraun
• LinkedInlinkedin.com/company/bbraun

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about B. Braun Melsungen